CNBX Pharmaceuticals Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2010 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-1.9M | $-307.2K | $-541.4K | $-270.0K | $-56.4K | $-115.0K |
| Depreciation & Amortization | — | — | — | — | — | — |
| Depreciation | $7.0K | $1.6K | $1.3K | $86 | $0 | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-863.6K | $-120.1K | $-179.1K | $-195.4K | $-27.2K | $6.0K |
| Investing Activities | ||||||
| Capital Expenditures | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-125.8K | $0 | — | — | — | $-183.7K |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $4.3M | $114.0K | — | — | $100.0K | — |
| Net Change in Cash | $3.3M | $-6.1K | $-73.5K | $26.0K | $72.8K | — |
| Free Cash Flow | — | — | — | — | — | — |